DT Investment Partners LLC trimmed its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 54.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,051 shares of the company's stock after selling 8,376 shares during the period. DT Investment Partners LLC's holdings in Corteva were worth $444,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. Scissortail Wealth Management LLC boosted its position in Corteva by 72,080.0% in the 4th quarter. Scissortail Wealth Management LLC now owns 3,609 shares of the company's stock valued at $206,000 after buying an additional 3,604 shares during the period. DnB Asset Management AS lifted its position in shares of Corteva by 39.0% in the 4th quarter. DnB Asset Management AS now owns 232,902 shares of the company's stock worth $13,266,000 after purchasing an additional 65,334 shares during the period. Brighton Jones LLC lifted its position in shares of Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company's stock worth $888,000 after purchasing an additional 11,760 shares during the period. Farther Finance Advisors LLC lifted its position in shares of Corteva by 13.9% in the 1st quarter. Farther Finance Advisors LLC now owns 4,387 shares of the company's stock worth $279,000 after purchasing an additional 536 shares during the period. Finally, BNP Paribas Financial Markets lifted its position in shares of Corteva by 56.3% in the 4th quarter. BNP Paribas Financial Markets now owns 1,460,898 shares of the company's stock worth $83,213,000 after purchasing an additional 526,150 shares during the period. 81.54% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts recently commented on CTVA shares. Jefferies Financial Group reissued a "buy" rating on shares of Corteva in a research report on Friday, June 6th. Morgan Stanley increased their target price on shares of Corteva from $65.00 to $71.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. UBS Group increased their target price on shares of Corteva from $74.00 to $76.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. The Goldman Sachs Group started coverage on shares of Corteva in a research report on Thursday, March 13th. They set a "buy" rating and a $71.00 target price for the company. Finally, Wells Fargo & Company increased their target price on shares of Corteva from $79.00 to $82.00 and gave the company an "overweight" rating in a research report on Monday, June 23rd. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $72.08.
View Our Latest Stock Analysis on CTVA
Corteva Price Performance
Shares of CTVA stock traded up $0.24 during mid-day trading on Friday, hitting $77.24. 1,419,340 shares of the stock were exchanged, compared to its average volume of 3,406,439. The firm has a fifty day moving average of $70.10 and a 200 day moving average of $63.95. The company has a quick ratio of 1.00, a current ratio of 1.44 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 52-week low of $50.30 and a 52-week high of $77.41. The company has a market cap of $52.69 billion, a PE ratio of 47.09, a price-to-earnings-growth ratio of 1.97 and a beta of 0.76.
Corteva (NYSE:CTVA - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.88 by $0.25. Corteva had a net margin of 6.77% and a return on equity of 7.84%. The business had revenue of $4.42 billion for the quarter, compared to analyst estimates of $4.56 billion. During the same period in the prior year, the company posted $0.89 EPS. The company's revenue for the quarter was down 1.7% on a year-over-year basis. Research analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.
Corteva Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Monday, June 16th. Investors of record on Friday, May 2nd were paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.88%. The ex-dividend date of this dividend was Monday, June 2nd. Corteva's dividend payout ratio is presently 41.46%.
Corteva Company Profile
(
Free Report)
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
See Also

Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.